You are here

anticoagulants

ATLAS ACS 2-TIMI 51: Rivaroxaban Beneficial in Low-Risk ACS Population

Forbes

Sun, 11/13/11 - 12:15 pm

acute coronary syndrome

Bristol, Pfizer clot drug fails to help ill patients

Reuters

Sun, 11/13/11 - 12:12 pm

Bristol-Myers Squibb

Astellas clot drug raises bleeding in heart study

Reuters

Tue, 08/30/11 - 09:44 am

Teva gets US FDA's tentative nod to market generic Argatrobar injection

Pharmabiz

Sat, 03/27/10 - 11:36 am

Teva Pharmaceuticals

Portola, Merck anticoagulant shows strong response

Bizjournals.com

Mon, 03/15/10 - 04:18 pm

Portola Pharmaceuticals

FDA Grants The Medicines Company Pediatric Exclusivity for Angiomax(R)

Yahoo

Fri, 06/19/09 - 08:36 am

Medicines Company

Pages